Director / Editor: Victor Teboul, Ph.D.
Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations,® aims to promote awareness of the major democratic principles on which tolerance is based.

Why the TGA should reschedule MDMA and psilocybin for the treatment of mental illness

By Sarah-Catherine Rodan, PhD candidate, University of Sydney
Samuel Banister, Team Leader in Medicinal Chemistry, University of Sydney
Share this article
The TGA is considering a proposal to reclassify psilocybin and MDMA from their current status as prohibited substances. This would allow psychiatrists to use these drugs to treat mental illness.

Read complete article

© The Conversation -

Follow us on ...
Facebook Twitter